SCHEDULE 13G/A 0000905148-25-000686 0001163653 XXXXXXXX LIVE 1 Common Stock, par value $0.0001 per share 03/31/2025 0001661460 Poseida Therapeutics, Inc. 73730P108 1 DNA Way South San Francisco CA 94080 Rule 13d-1(b) NOMURA HOLDINGS INC M0 0 0 0 0 0 N 0 HC NOMURA GLOBAL FINANCIAL PRODUCTS INC DE 0 0 0 0 0 N 0 BD Poseida Therapeutics, Inc. 1 DNA Way, South San Francisco, California, 94080 Nomura Holdings, Inc. Nomura Global Financial Products, Inc. Nomura Holdings, Inc.: 13-1, Nihonbashi 1-chome, Chuo-ku, Tokyo 103-8645, Japan Nomura Global Financial Products, Inc.: Worldwide Plaza 309 West 49th Street New York, NY 10019 Nomura Holdings, Inc.: Japan Nomura Global Financial Products, Inc.: Delaware N BD HC Items 5-11 of the cover pages are incorporated by reference. Items 5-11 of the cover pages are incorporated by reference. Items 5-11 of the cover pages are incorporated by reference. Items 5-11 of the cover pages are incorporated by reference. Items 5-11 of the cover pages are incorporated by reference. Items 5-11 of the cover pages are incorporated by reference. N Y Y N See Exhibit B Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit A - Joint Filing Agreement Exhibit B - Subsidiaries NOMURA HOLDINGS INC /s/ Samir Patel 05/15/2025 NOMURA GLOBAL FINANCIAL PRODUCTS INC /s/ Samir Patel 05/15/2025